| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jun 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.38 | 60,000 | 22.80 k | 60,000 |
| 17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 10,520 | 77.01 k | 10,520 |
| 28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 8,823 | 8.47 k | 8,823 |
| 27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 29.1 | 30,000 | 873.00 k | 0 |
| 7 Feb 24 | ADVM Adverum Biotechnologies | Common Stock | Buy | Acquire P | No | No | 1.35 | 100,000 | 135.00 k | 100,000 |
| 25 Oct 23 | ALGS Aligos Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.7568 | 183,083 | 138.56 k | 183,083 |
| 25 Oct 23 | ALGS Aligos Therapeutics | Warrant Common Stock | Grant | Acquire A | No | No | 0.125 | 91,541 | 11.44 k | 91,541 |
